Nellix Endovascular, a Palo Alto, Calif., medical-device maker, raised $6.5 million in a third funding round, I’ve learned. The startup is developing a new treatment for repairing blood-vessel flaws in the chest and abdomen.
Those flaws, known as aneurysms, are thin-walled “bubbles” in blood vessels that can rupture on short notice, often fatally. The Nellix device and treatment apparently injects some form of goop into these aneurysms, filling and sealing them in order to prevent rupture.
Investors in the round included Essex Woodlands Health Ventures and Incept.
Tags: aneurysms, co:Nellix, deal, inv:Essex-Woodlands-Health-Ventures, inv:Incept, medical-devices
2 Trackbacks
7:21 pm
Exclusive news on life-science start-up fundings: Cameron, Nellix, Miramar, Chestnut » VentureBeat said:
[...] Nellix (Palo Alto, Calif.), a device-maker focused on aneurysms [...]
6:29 am
Life-science briefing: Monday, March 17, 2008 » VentureBeat said:
[...] Nellix raises $6.5M for aneurysm grafts (VBLS exclusive) [...]